Kraig Biocraft Laboratories (KBLB) Income from Continuing Operations (2010 - 2025)

Kraig Biocraft Laboratories (KBLB) has 15 years of Income from Continuing Operations data on file, last reported at 787621.0 in Q4 2025.

• For the quarter ending Q4 2025, Income from Continuing Operations rose 7.52% year-over-year to 787621.0; the trailing twelve-month figure through Dec 2025 stood at 3623353.0 (down 6.6% YoY), and the FY2025 full-year result was 3858583.0, down 7.8% from the prior year.
• Income from Continuing Operations improved to 787621.0 in Q4 2025, from 1509566.0 in the prior quarter.
• In the past five years, Income from Continuing Operations ranged from a high of 433200.0 in Q3 2024 to a low of 3187147.0 in Q3 2021.
• A 5-year average of 1096994.45 and a median of 896168.5 in 2021 frame the typical range for Income from Continuing Operations.
• Across the five-year window, Income from Continuing Operations sank 384.14% in 2021 and surged 74.57% in 2022, its largest moves.
• Tracing KBLB's Income from Continuing Operations over 5 years: stood at 1164219.0 in 2021, then gained by 18.67% to 946847.0 in 2022, then sank by 39.9% to 1324634.0 in 2023, then surged by 35.7% to 851675.0 in 2024, then rose by 7.52% to 787621.0 in 2025.
• Business Quant data shows KBLB's Income from Continuing Operations at 787621.0 in Q4 2025, 1509566.0 in Q3 2025, and 726133.0 in Q2 2025.